Accumulation of genetic and epigenetic alterations in normal cells and cancer risk
暂无分享,去创建一个
[1] S. Tsunoda,et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.
[2] Peter J. Campbell,et al. Somatic mutant clones colonize the human esophagus with age , 2018, Science.
[3] Daniel B. Sloan,et al. Detecting Rare Mutations and DNA Damage with Sequencing-Based Methods. , 2018, Trends in biotechnology.
[4] R. Handsaker,et al. Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.
[5] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[6] Jesse J. Salk,et al. Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations , 2018, Nature Reviews Genetics.
[7] T. Ushijima,et al. Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues , 2018, Proceedings of the National Academy of Sciences.
[8] T. Graham,et al. An evolutionary perspective on field cancerization , 2017, Nature Reviews Cancer.
[9] T. Ushijima,et al. A novel method to quantify base substitution mutations at the 10-6 per bp level in DNA samples. , 2017, Cancer letters.
[10] F. Markowetz,et al. Copy-number signatures and mutational processes in ovarian carcinoma , 2017, Nature Genetics.
[11] T. Ushijima,et al. Degree of methylation burden is determined by the exposure period to carcinogenic factors , 2017, Cancer science.
[12] N. Yamamichi,et al. High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study , 2016, Gut.
[13] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[14] J. DeGregori,et al. The evolution of lifespan and age-dependent cancer risk. , 2016, Trends in cancer.
[15] Arthur P. Grollman,et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing , 2016, Proceedings of the National Academy of Sciences.
[16] S. Linnarsson,et al. Single-cell genomics: coming of age , 2016, Genome Biology.
[17] R. Dummer,et al. The Genetic Evolution of Melanoma from Precursor Lesions. , 2015, The New England journal of medicine.
[18] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[19] T. Ushijima,et al. Frequent involvement of chromatin remodeler alterations in gastric field cancerization. , 2015, Cancer letters.
[20] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[21] Rochelle L. Tiedemann,et al. Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis , 2014, Oncotarget.
[22] Y. Matsumoto,et al. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection. , 2014, Gastroenterology.
[23] N. Yamamichi,et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study , 2014, Gut.
[24] J. Berkhof,et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. , 2014, The Lancet. Oncology.
[25] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[26] Benjamin D. Simons,et al. Unravelling stem cell dynamics by lineage tracing , 2013, Nature Reviews Molecular Cell Biology.
[27] X. Xie,et al. Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell , 2012, Science.
[28] Young-Joon Kim,et al. Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells. , 2012, Carcinogenesis.
[29] Joe W. Gray,et al. Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? , 2012, Breast Cancer Research and Treatment.
[30] Jesse J. Salk,et al. Detection of ultra-rare mutations by next-generation sequencing , 2012, Proceedings of the National Academy of Sciences.
[31] K. Straif,et al. Preventable exposures associated with human cancers. , 2011, Journal of the National Cancer Institute.
[32] S. Baylin,et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. , 2011, Cancer cell.
[33] N. Watanabe,et al. Revisit of Field Cancerization in Squamous Cell Carcinoma of Upper Aerodigestive Tract: Better Risk Assessment with Epigenetic Markers , 2011, Cancer Prevention Research.
[34] K. Kinzler,et al. Detection and quantification of rare mutations with massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.
[35] Z. Herceg,et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. , 2011, Journal of hepatology.
[36] S. Davis,et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate , 2010, Oncogene.
[37] Nayoung Kim,et al. Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer , 2010, Virchows Archiv.
[38] T. Ushijima,et al. Abstract 176: The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands , 2010 .
[39] T. Ushijima,et al. Methylation destiny: Moira takes account of histones and RNA polymerase II , 2010, Epigenetics.
[40] Takeshi Toyoda,et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. , 2010, Cancer research.
[41] S. Hirohashi,et al. Genome‐wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage , 2010, Cancer science.
[42] Chun Meng Song,et al. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. , 2009, European journal of cancer.
[43] M. Kaminishi,et al. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history , 2009, Cancer.
[44] Qin Li,et al. Alterations of histone modifications by cobalt compounds. , 2009, Carcinogenesis.
[45] A. Bhattacharyya,et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. , 2009, Cancer research.
[46] M. Stratton,et al. The cancer genome , 2009, Nature.
[47] T. Yeatman,et al. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. , 2008, Cancer research.
[48] C. Boland,et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma , 2008, Hepatology.
[49] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[50] Zohar Yakhini,et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.
[51] P. Laird,et al. Epigenetic stem cell signature in cancer , 2007, Nature Genetics.
[52] Kelly M. McGarvey,et al. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.
[53] Timothy J. Yeatman,et al. Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue , 2006, Clinical Cancer Research.
[54] T. Gotoda,et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? , 2006, Gastric Cancer.
[55] A. Kaneda,et al. High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk , 2006, Clinical Cancer Research.
[56] Gary L Rosner,et al. Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.
[57] C. R. Leemans,et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.
[58] N. Ahuja,et al. Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.
[59] T. Nohmi,et al. Recent advances in the protocols of transgenic mouse mutation assays. , 2000, Mutation research.
[60] S. Hirohashi,et al. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma , 2000, Hepatology.
[61] M. Carrington,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.
[62] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[63] J. T. Reardon,et al. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[64] K. Hemminki,et al. Assay of different photoproducts after UVA, B and C irradiation of DNA and human skin explants. , 1996, Carcinogenesis.
[65] J. Short,et al. The use of transgenic mice for short-term, in vivo mutagenicity testing. , 1990, Genetic analysis, techniques and applications.
[66] J Vijg,et al. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[67] D. Slaughter,et al. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.
[68] S. Baylin,et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.